Author

M. Büttner-Herold

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

H. Bruns· 2 shared A. Broijl· 1 shared A. Gerbitz· 1 shared A. Mackensen· 1 shared A. Moosmann· 1 shared A. Seegebarth· 1 shared C. Fokkema· 1 shared F. Gay· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. Bruns

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma

M. M. de Jong, C. Fokkema, N. Papazian, T. van Heusden, M. Vermeulen, R. Hoogenboezem, G. van Beek, S. Tahri, M. A. Sanders, P. van de Woestijne, F. Gay, P. Moreau, M. Büttner-Herold, H. Bruns, M. van Duin, , T. Cupedo

The paper identifies a neutrophil-stromal cell feedback loop in multiple myeloma that promotes BAFF-rich inflammation, persisting after treatment and suggesting dual targeting strategies.

bioRxiv · Mar 3, 2023 · PreprintImmunology

Reconstitution of T cell immunity against EBV in the immunocompromised host by adoptive transfer of peptide-stimulated T cells after allogeneic stem cell transplantation

M. F. Lammoglia Cobo, J. Ritter, R. Gary, V. Seitz, J. Mautner, M. Aigner, S. Völkl, S. Schaffer, S. Moi, A. Seegebarth, H. Bruns, W. Rösler, K. Amann, M. Büttner-Herold, S. Hennig, , A. Gerbitz

The paper demonstrates that adoptive transfer of peptide-stimulated donor-derived EBV-specific T cells can reconstitute EBV-specific immunity and control EBV reactivation in an immunocompromised patient post-transplant.

bioRxiv · Dec 16, 2021 · PreprintImmunology